TB-500 research overview

What the compound is

TB-500 is a synthetic fragment corresponding to an active region of thymosin β4, an actin-binding protein. The supplied material is an acetylated nine-residue peptide rather than the full-length protein.

How it appears in the research literature

Laboratory research referencing TB-500 has focused on cell migration, angiogenesis, and tissue-remodeling model systems. Study designs commonly rely on cell-culture migration assays with defined controls.

Co-formulated research material

ATMI Labs also lists a BPC-157 / TB-500 co-formulation for laboratories that study both pathways within one experimental series. Co-formulated blends are documented as a single lot with a single Certificate of Analysis.

Handling and laboratory considerations

Lyophilized research peptides are generally handled as temperature-sensitive laboratory materials. Storage, reconstitution solvent, and container choice are determined by the receiving laboratory's own written protocol, not by the supplier.

Every ATMI Labs lot is released with batch documentation so that identity and purity figures used in a study can be traced back to the specific lot in hand.

• Confirm the lot identifier on the vial label against the published Certificate of Analysis.
• Record lot, strength, and receipt date in the laboratory inventory before use.
• Follow institutional handling, labeling, and disposal procedures for research chemicals.

Research use scope

TB-500 supplied by ATMI Labs is sold exclusively for laboratory research and analytical purposes. It is not a drug, supplement, cosmetic, or food, and it is not intended for human or veterinary use.

Nothing on this page describes therapeutic use, dosing, or clinical outcomes. Literature referenced in general terms describes laboratory and preclinical model systems only, and findings in such systems do not establish effects in humans.